Results 231 to 240 of about 1,389,478 (387)

Higher hospital volume is associated with lower mortality for patients with cardiogenic shock and mechanical circulatory support

open access: yesEuropean Journal of Heart Failure, EarlyView.
Is cardiogenic shock (CS) best treated locally with short transport times and multiple shock centres? Or is a central, standardized provision of care for CS and especially use of mechanical circulatory support (MCS) better for patients? Annualized volume of CS and MCS cases vary widely at the hospital level.
Angela Dettling   +9 more
wiley   +1 more source

First‐Line Osimertinib in Patients with EGFR‐Mutant Advanced Non‐Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study

open access: yesThe Oncologist, EarlyView., 2021
Abstract Lessons Learned Osimertinib has confirmed effectiveness in this real‐world population of patients with EGFR‐mutant advanced non‐small cell lung cancer. Thromboembolic events occur more frequently than previously reported, suggesting a thrombotic diathesis that requires further investigation. Patients with at least three metastatic sites, brain
Martina Lorenzi   +21 more
wiley   +1 more source

Deep phenotyping of heart failure with preserved ejection fraction through multi‐omics integration

open access: yesEuropean Journal of Heart Failure, EarlyView.
Deep phenotyping of of heart failure with preserved ejection fraction (HFpEF) through multi‐omics integration. AI, artificial intelligence. Aims Heart failure with preserved ejection fraction (HFpEF) has become the predominant form of heart failure and a leading cause of global cardiovascular morbidity and mortality.
Jakob Versnjak   +15 more
wiley   +1 more source

Incidence of major cardiovascular events in patients with metabolic dysfunction‐associated steatotic liver disease in the general population

open access: yesEuropean Journal of Heart Failure, EarlyView.
Aims Major adverse cardiovascular events (MACE) related to cardiovascular disease are a major cause of death in patients with metabolic dysfunction‐associated steatotic liver disease (MASLD). We explored the impact of MASLD on incident MACE and overall mortality in the general population in Germany.
Yvonne Huber   +15 more
wiley   +1 more source

The influence factors on the resolution of pulmonary embolism by CT pulmonary angiography. [PDF]

open access: yesThromb J
Liu Z   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy